However, CT did not affect circulating irisin levels in overweight or obese participants with MetS (SMD = 0.21, 95% CI [−0.25–0.68], p = 0.36; I2 = 38.7%, p for heterogeneity = 0.18) (Fig. 5). Here, FNDC5 is linked to metabolic syndrome.